Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration

PURPOSE: To report the reasons for treatment discontinuation within 5 years in patients receiving intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD). METHODS: A retrospective case-notes review of patients commenced on anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhingra, Narendra, Upasani, Deepa, Ghanchi, Faruque D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Special Focus, Retina, Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359266/
https://www.ncbi.nlm.nih.gov/pubmed/35647983
http://dx.doi.org/10.4103/ijo.IJO_3066_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359266/
https://www.ncbi.nlm.nih.gov/pubmed/35647983
http://dx.doi.org/10.4103/ijo.IJO_3066_21

Ejemplares similares